These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19895110)

  • 1. Diagnosis of oral submucous fibrosis with optical coherence tomography.
    Lee CK; Tsai MT; Lee HC; Chen HM; Chiang CP; Wang YM; Yang CC
    J Biomed Opt; 2009; 14(5):054008. PubMed ID: 19895110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating oral lesions in different carcinogenesis stages with optical coherence tomography.
    Tsai MT; Lee CK; Lee HC; Chen HM; Chiang CP; Wang YM; Yang CC
    J Biomed Opt; 2009; 14(4):044028. PubMed ID: 19725739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective indicators for diagnosis of oral cancer using optical coherence tomography.
    Tsai MT; Lee HC; Lee CK; Yu CH; Chen HM; Chiang CP; Chang CC; Wang YM; Yang CC
    Opt Express; 2008 Sep; 16(20):15847-62. PubMed ID: 18825221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study.
    Vedeswari CP; Jayachandran S; Ganesan S
    Indian J Dent Res; 2009; 20(3):261-7. PubMed ID: 19884705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of oral precancer with optical coherence tomography.
    Lee CK; Chi TT; Wu CT; Tsai MT; Chiang CP; Yang CC
    Biomed Opt Express; 2012 Jul; 3(7):1632-46. PubMed ID: 22808434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of an oral cancer lesion with swept-source optical coherence tomography.
    Tsai MT; Lee HC; Lu CW; Wang YM; Lee CK; Yang CC; Chiang CP
    J Biomed Opt; 2008; 13(4):044012. PubMed ID: 19021340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo autofluorescence spectroscopy of oral premalignant and malignant lesions: distortion of fluorescence intensity by submucous fibrosis.
    Tsai T; Chen HM; Wang CY; Tsai JC; Chen CT; Chiang CP
    Lasers Surg Med; 2003; 33(1):40-7. PubMed ID: 12866120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function.
    Lin HJ; Lin JC
    Oral Dis; 2007 Jul; 13(4):407-13. PubMed ID: 17577328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the pattern of copper as an etiological factor in oral submucous fibrosis: a cytological study.
    Sharma A; Sahni P; Nayak MT; Singhvi A; Kumar R
    J Exp Ther Oncol; 2014; 10(4):317-23. PubMed ID: 25509987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-speed, high-resolution optical coherence tomography retinal imaging with a frequency-swept laser at 850 nm.
    Srinivasan VJ; Huber R; Gorczynska I; Fujimoto JG; Jiang JY; Reisen P; Cable AE
    Opt Lett; 2007 Feb; 32(4):361-3. PubMed ID: 17356653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on the clinical classification of oral submucous fibrosis].
    Gao Y; Ling T; Tang J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Aug; 18(4):250-1, 258. PubMed ID: 12539535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of traumatic and malignant oral ulcers with optical coherence tomography: A comparison between histopathological and ultrastructural findings.
    Gambino A; Cafaro A; Broccoletti R; Turotti L; Karimi D; Haddad GE; Hopper C; Porter SR; Chiusa L; Arduino PG
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():103019. PubMed ID: 35850459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auto-fluorescence spectra of oral submucous fibrosis.
    Chen HM; Wang CY; Chen CT; Yang H; Kuo YS; Lan WH; Kuo MY; Chiang CP
    J Oral Pathol Med; 2003 Jul; 32(6):337-43. PubMed ID: 12787040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomechanical signatures of oral submucous fibrosis in sub-epithelial connective tissue.
    Anura A; Das D; Pal M; Paul RR; Das S; Chatterjee J
    J Mech Behav Biomed Mater; 2017 Jan; 65():705-715. PubMed ID: 27750161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis.
    Desai RS; Mamatha GS; Khatri MJ; Shetty SJ
    Oral Oncol; 2010 Jul; 46(7):553-8. PubMed ID: 20538504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swept source optical coherence tomography using an all-fiber 1300-nm ring laser source.
    Choma MA; Hsu K; Izatt JA
    J Biomed Opt; 2005; 10(4):44009. PubMed ID: 16178643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical study of oral submucous fibrosis.
    Haque MF; Harris M; Meghji S; Speight PM
    J Oral Pathol Med; 1997 Feb; 26(2):75-82. PubMed ID: 9049906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography system with no high-precision scanning stage and stage controller.
    Lo YL; Kuo CI; Chuang CH; Yan ZZ
    Appl Opt; 2004 Jul; 43(21):4142-9. PubMed ID: 15291056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial growth fraction and expression of p53 tumour suppressor gene in oral submucous fibrosis.
    Cox SC; Walker DM
    Aust Dent J; 1996 Apr; 41(2):91-6. PubMed ID: 8670041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parabolic BM-scan technique for full range Doppler spectral domain optical coherence tomography.
    Jaillon F; Makita S; Yabusaki M; Yasuno Y
    Opt Express; 2010 Jan; 18(2):1358-72. PubMed ID: 20173963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.